Churg-Strauss syndrome: The use of cyclophosphamide in mononeuritis [7]

Rheumatology

Volumn 42, Issue 2, 2003, Pages 390-391

  Hoi, A Y ^a   Morand, E F ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXYCYCLINE; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ANAMNESIS; ASTHMA; CASE REPORT; CHRONIC SINUSITIS; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; COLITIS; DISEASE CLASSIFICATION; DRUG RESPONSE; HUMAN; LETTER; MALE; MONONEUROPATHY MULTIPLEX; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; CHURG-STRAUSS SYNDROME; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MONONEUROPATHIES;

EID: 0037296366     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg067     Document Type: Letter

References (10)

1. Langford CA, Klippel JH, Balow JE et al. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease: part 2: inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity. Ann Intern Med 1998;129:49-58.
2. Solans R, Bosch J, Perez-Bocanegra C et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001;40:763-71.
3. Gross W. Churg-Strauss syndrome: update on recent developments. Curr Opin Rheumatol 2002;14:11-4.
4. Fauci A, Katz P, Haynes B, Wolff S. Cyclophosphamide therapy of severe necrotizing vasculitis. N Engl J Med 1979;301:235-8.
5. Gayraud M, Guillevin L, Toumelin P et al. The French Vasculitis Study Group. Long term follow-up of polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75.
6. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
7. Guillevin L, Lhote F, Gherardi R. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Clinical aspects, neurological manifestations and treatment. Neurol Clin 1997;15:865-86.
8. Guillevin L, Lhote F, Gayraud M et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28.
9. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37.
10. Gayraud M, Guillevin L, Cohen P et al. The French Cooperative Study Group for Vasculitides. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: Comparison of steroids and oral or pulse cyclophosphamide in 25 patients. Br J Rheumatol 1997;36:1290-7.